The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Trifluridine/tipiracil in combination with oxaliplatin and either bevacizumab or nivolumab: Results of the expansion part of a phase I study in patients with metastatic colorectal cancer.
 
Roberto Bordonaro
Honoraria - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Novartis; Novartis; Novartis; Novartis
Consulting or Advisory Role - Novartis; Novartis; Novartis; Novartis
Speakers' Bureau - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Sanofi; Sanofi; Sanofi; Sanofi
Travel, Accommodations, Expenses - Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; Bayer; Bayer; Bayer; Bayer
 
Aitana Calvo
No Relationships to Disclose
 
Alessandra Auriemma
No Relationships to Disclose
 
Antoine Hollebecque
Honoraria - Merck Serono; Merck Serono; Merck Serono; Merck Serono
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); Gritstone Bio; Gritstone Bio; Gritstone Bio; Gritstone Bio; Incyte (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Spectrum Pharmaceuticals (Inst); Spectrum Pharmaceuticals (Inst); Spectrum Pharmaceuticals (Inst); Spectrum Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Amgen; Amgen; Amgen; Amgen; AstraZeneca/MedImmune; AstraZeneca/MedImmune; AstraZeneca/MedImmune; AstraZeneca/MedImmune; Lilly; Lilly; Lilly; Lilly; SERVIER; SERVIER; SERVIER; SERVIER
Other Relationship - Abbvie; Abbvie; Abbvie; Abbvie; Agios; Agios; Agios; Agios; Amgen; Amgen; Amgen; Amgen; argenx; argenx; argenx; argenx; Arno Therapeutics; Arno Therapeutics; Arno Therapeutics; Arno Therapeutics; Astex Pharmaceuticals; Astex Pharmaceuticals; Astex Pharmaceuticals; Astex Pharmaceuticals; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AVEO; AVEO; AVEO; AVEO; Bayer; Bayer; Bayer; Bayer; Blueprint Medicines; Blueprint Medicines; Blueprint Medicines; Blueprint Medicines; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Chugai Pharma; Chugai Pharma; Chugai Pharma; Chugai Pharma; Clovis Oncology; Clovis Oncology; Clovis Oncology; Clovis Oncology; Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; Debiopharm Group; Debiopharm Group; Debiopharm Group; Debiopharm Group; Eisai; Eisai; Eisai; Eisai; Exelixis; Exelixis; Exelixis; Exelixis; FORMA Therapeutics; FORMA Therapeutics; FORMA Therapeutics; FORMA Therapeutics; GamaMabs Pharma; GamaMabs Pharma; GamaMabs Pharma; GamaMabs Pharma; Genentech; Genentech; Genentech; Genentech; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; H3 Biomedicine; H3 Biomedicine; H3 Biomedicine; H3 Biomedicine; Innate Pharma; Innate Pharma; Innate Pharma; Innate Pharma; Janssen-Cilag; Janssen-Cilag; Janssen-Cilag; Janssen-Cilag; Kyowa Hakko Kirin; Kyowa Hakko Kirin; Kyowa Hakko Kirin; Kyowa Hakko Kirin; Lilly; Lilly; Lilly; Lilly; Loxo; Loxo; Loxo; Loxo; Lytix Biopharma; Lytix Biopharma; Lytix Biopharma; Lytix Biopharma; MedImmune; MedImmune; MedImmune; MedImmune; Menarini; Menarini; Menarini; Menarini; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Merrimack; Merrimack; Merrimack; Merrimack; Merus; Merus; Merus; Merus; Millenium Pharamceuticals; Millenium Pharamceuticals; Millenium Pharamceuticals; Millenium Pharamceuticals; Nanobiotix; Nanobiotix; Nanobiotix; Nanobiotix; Nektar; Nektar; Nektar; Nektar; Novartis; Novartis; Novartis; Novartis; Octimet; Octimet; Octimet; Octimet; Oncoethix; Oncoethix; Oncoethix; Oncoethix; Onyx; Onyx; Onyx; Onyx; Orion; Orion; Orion; Orion; Oryzon Genomics; Oryzon Genomics; Oryzon Genomics; Oryzon Genomics; Pfizer; Pfizer; Pfizer; Pfizer; Pierre Fabre; Pierre Fabre; Pierre Fabre; Pierre Fabre; Roche; Roche; Roche; Roche; Roche/Genentech; Roche/Genentech; Roche/Genentech; Roche/Genentech; Sanofi/Aventis; Sanofi/Aventis; Sanofi/Aventis; Sanofi/Aventis; SERVIER; SERVIER; SERVIER; SERVIER; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Tesaro; Tesaro; Tesaro; Tesaro; Xencor; Xencor; Xencor; Xencor
 
Gabor Rubovszky
No Relationships to Disclose
 
Mark P. Saunders
Honoraria - Amgen; Amgen; Amgen; Amgen; Merck; Merck; Merck; Merck; Roche; Roche; Roche; Roche; SERVIER; SERVIER; SERVIER; SERVIER
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; Merck; Merck; Merck; Merck; Roche; Roche; Roche; Roche; SERVIER; SERVIER; SERVIER; SERVIER
 
Zsuzsanna Papai
No Relationships to Disclose
 
Gerald W. Prager
Honoraria - Amgen; Amgen; Amgen; Amgen; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Lilly; Lilly; Lilly; Lilly; Merck; Merck; Merck; Merck; MSD; MSD; MSD; MSD; Pierre Fabre; Pierre Fabre; Pierre Fabre; Pierre Fabre; Roche; Roche; Roche; Roche; Sanofi; Sanofi; Sanofi; Sanofi; SERVIER; SERVIER; SERVIER; SERVIER
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Lilly; Lilly; Lilly; Lilly; Merck; Merck; Merck; Merck; MSD; MSD; MSD; MSD; Pierre Fabre; Pierre Fabre; Pierre Fabre; Pierre Fabre; Roche; Roche; Roche; Roche; Sanofi; Sanofi; Sanofi; Sanofi; SERVIER; SERVIER; SERVIER; SERVIER
 
Alexander Stein
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Merck KGaA; Merck KGaA; Merck KGaA; Merck KGaA; MSD; MSD; MSD; MSD; Roche; Roche; Roche; Roche
Speakers' Bureau - Amgen; Amgen; Amgen; Amgen; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Lilly; Lilly; Lilly; Lilly; Merck KGaA; Merck KGaA; Merck KGaA; Merck KGaA; Roche; Roche; Roche; Roche; Sanofi; Sanofi; Sanofi; Sanofi; Servier; Servier; Servier; Servier
Research Funding - Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Merck KGaA (Inst); Merck KGaA (Inst); Merck KGaA (Inst); Merck KGaA (Inst); Roche (Inst); Roche (Inst); Roche (Inst); Roche (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst); SERVIER (Inst); SERVIER (Inst); SERVIER (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Merck KGaA; Merck KGaA; Merck KGaA; Merck KGaA; Roche; Roche; Roche; Roche
 
Thierry Andre
Honoraria - AMGEN; AMGEN; AMGEN; AMGEN; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Pierre Fabre; Pierre Fabre; Pierre Fabre; Pierre Fabre; PRMA Consulting; PRMA Consulting; PRMA Consulting; PRMA Consulting; Roche/Genentech; Roche/Genentech; Roche/Genentech; Roche/Genentech; Sanofi; Sanofi; Sanofi; Sanofi; SERVIER; SERVIER; SERVIER; SERVIER; Ventana Medical Systems; Ventana Medical Systems; Ventana Medical Systems; Ventana Medical Systems; Xbiotech; Xbiotech; Xbiotech; Xbiotech
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; AstraZeneca/MedImmune; AstraZeneca/MedImmune; AstraZeneca/MedImmune; AstraZeneca/MedImmune; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Clovis Oncology; Clovis Oncology; Clovis Oncology; Clovis Oncology; Guardant Health; Guardant Health; Guardant Health; Guardant Health; HalioDX; HalioDX; HalioDX; HalioDX; MSD Oncology; MSD Oncology; MSD Oncology; MSD Oncology; Mundipharma; Mundipharma; Mundipharma; Mundipharma; Roche/Genentech; Roche/Genentech; Roche/Genentech; Roche/Genentech; SERVIER; SERVIER; SERVIER; SERVIER; Tesaro; Tesaro; Tesaro; Tesaro
Travel, Accommodations, Expenses - Amgen; Amgen; Amgen; Amgen; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; MSD Oncology; MSD Oncology; MSD Oncology; MSD Oncology; MSD Oncology; MSD Oncology; MSD Oncology; MSD Oncology; Roche; Roche; Roche; Roche; Roche/Genentech; Roche/Genentech; Roche/Genentech; Roche/Genentech; Ventana Medical Systems; Ventana Medical Systems; Ventana Medical Systems; Ventana Medical Systems
 
Guillem Argiles
Consulting or Advisory Role - Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche; Roche; Roche; Roche; Roche; SERVIER; SERVIER; SERVIER; SERVIER
Travel, Accommodations, Expenses - Amgen; Amgen; Amgen; Amgen; Bayer; Bayer; Bayer; Bayer; Roche; Roche; Roche; Roche; SERVIER; SERVIER; SERVIER; SERVIER
 
Antonio Cubillo
No Relationships to Disclose
 
Laetitia Dahan
Honoraria - Amgen; Amgen; Amgen; Amgen; Baxalta; Baxalta; Baxalta; Baxalta; Celgene; Celgene; Celgene; Celgene; Lilly; Lilly; Lilly; Lilly; Sanofi; Sanofi; Sanofi; Sanofi
 
Julien Edeline
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; BTG; BTG; BTG; BTG; Eisai; Eisai; Eisai; Eisai; Ipsen; Ipsen; Ipsen; Ipsen; MSD; MSD; MSD; MSD
Research Funding - Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Amgen; Amgen; Amgen; Amgen; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Roche; Roche; Roche; Roche
 
Catherine Leger
Employment - SERVIER; SERVIER; SERVIER; SERVIER
 
Nadia Amellal
Employment - SERVIER; SERVIER; SERVIER; SERVIER
 
Valerie Cattan
Employment - SERVIER; SERVIER; SERVIER; SERVIER
 
Josep Tabernero
Consulting or Advisory Role - Array BioPharma; Array BioPharma; Array BioPharma; Array BioPharma; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; Bayer; BeiGene; BeiGene; BeiGene; BeiGene; Biocartis; Biocartis; Biocartis; Biocartis; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Chugai Pharma; Chugai Pharma; Chugai Pharma; Chugai Pharma; Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine; Genentech; Genentech; Genentech; Genentech; Genmab; Genmab; Genmab; Genmab; HalioDx; HalioDx; HalioDx; HalioDx; Halozyme; Halozyme; Halozyme; Halozyme; Imugene; Imugene; Imugene; Imugene; Inflection Biosciences; Inflection Biosciences; Inflection Biosciences; Inflection Biosciences; Ipsen; Ipsen; Ipsen; Ipsen; Kura Oncology; Kura Oncology; Kura Oncology; Kura Oncology; Lilly; Lilly; Lilly; Lilly; Menarini; Menarini; Menarini; Menarini; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Merrimack; Merrimack; Merrimack; Merrimack; Merus; Merus; Merus; Merus; Molecular Partners; Molecular Partners; Molecular Partners; Molecular Partners; MSD; MSD; MSD; MSD; Novartis; Novartis; Novartis; Novartis; Peptomyc; Peptomyc; Peptomyc; Peptomyc; Pfizer; Pfizer; Pfizer; Pfizer; Pharmacyclics; Pharmacyclics; Pharmacyclics; Pharmacyclics; ProteoDesign; ProteoDesign; ProteoDesign; ProteoDesign; Rafael Pharmaceuticals; Rafael Pharmaceuticals; Rafael Pharmaceuticals; Rafael Pharmaceuticals; Roche; Roche; Roche; Roche; Roche; Roche; Roche; Roche; Sanofi; Sanofi; Sanofi; Sanofi; Seagen; Seagen; Seagen; Seagen; Seagen; Seagen; Seagen; Seagen; Servier; Servier; Servier; Servier; Symphogen; Symphogen; Symphogen; Symphogen; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; VCN Biosciences; VCN Biosciences; VCN Biosciences; VCN Biosciences